APA (7th ed.) Citation

Lin, C., Huang, P., Hsieh, C., Hsu, C., Liau, C., Huang, S., . . . Wang, H. (2024). Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy. Nutrition & Cancer, 76(7), 628. https://doi.org/10.1080/01635581.2024.2352185

Chicago Style (17th ed.) Citation

Lin, Chien-Yu, Pei-Wei Huang, Chia-Hsun Hsieh, Cheng-Lung Hsu, Chi-Ting Liau, Shiang-Fu Huang, Chun-Ta Liao, Tung-Chieh Chang, and Hung-Ming Wang. "Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy." Nutrition & Cancer 76, no. 7 (2024): 628. https://doi.org/10.1080/01635581.2024.2352185.

MLA (9th ed.) Citation

Lin, Chien-Yu, et al. "Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy." Nutrition & Cancer, vol. 76, no. 7, 2024, p. 628, https://doi.org/10.1080/01635581.2024.2352185.